VAERS reports by lot

Pfizer COVID-19 lot EN6955: VAERS reports

51 VAERS reports list lot EN6955 as a Pfizer COVID-19 vaccine, received between 2021-03-17 and 2023-01-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
51
Reports
25%
Marked serious
3
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5727%
Neurological4421%
Cardiac / Cardiovascular3617%
Gastrointestinal2010%
Respiratory147%
Musculoskeletal126%
Dermatological (non-injection-site)73%
Allergic / Anaphylactic63%
Injection-site / Local reaction52%
Thrombotic / Hematological42%
Psychiatric / Neuropsychiatric31%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California11
Texas8
Washington4
Florida4
Virginia4
Colorado3
Ohio2
Missouri2
Illinois1
Nevada1
Mississippi1
Vermont1

Reports by month received

2021-039
2021-0410
2021-052
2021-062
2021-077
2021-082
2021-093
2021-104
2021-111
2021-121
2022-013
2022-021
2022-032
2022-071
2022-081
2022-091
2023-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.